Drugs / AMG 786
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05406115 | Jul 2022 → Aug 2023 | obesity disorder | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 786 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05406115 ↗ |
| Route | Oral | “Oral tablet” NCT05406115 ↗ |